Kouseki Hirade
Papers
1
Total Citations
6
H-Index
1
About
Kouseki Hirade is a cancer geneticist whose research centers on the molecular mechanisms driving renal cell carcinoma, particularly the role of chromosomal instability and the *VHL* tumor suppressor gene. In his landmark 2022 study, Hirade elucidated a novel pathway for multifocal clear cell renal cell carcinoma (ccRCC), demonstrating that a derivative chromosome 3 loss from a t(3;6) translocation, followed by distinct *VHL* mutations in separate tumor foci, underlies the disease’s multicentric nature. This work, which has garnered 6 citations, provides critical insight into how early chromosomal events can create a permissive environment for subsequent *VHL* inactivation—a key driver of ccRCC. By tracing the lineage of *VHL* mutations back to a shared chromosomal rearrangement, Hirade’s findings have significant implications for understanding tumor heterogeneity and the clonal evolution of kidney cancer. His research bridges cytogenetics and functional genomics, offering a refined model for how loss of pVHL function, through both structural and mutational mechanisms, promotes HIFα accumulation and tumorigenesis. Hirade’s contributions are foundational for researchers exploring the early genetic events in ccRCC and the development of targeted therapies against HIF-driven pathways.
Research Focus
Key Achievements
Top Papers
- 1